GlassScriptPhysician profile
Mallory B Johnson
NPI 1518520238
$819.38
in general payments reported to CMS, 2019-2025
18 companies · $399 in 2025
The $399 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $93.07 · 2022: $116 · 2023: $138 · 2024: $72.33 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $521.17 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $120.30 | 2022-2025 | Tecvayli, Darzalex |
| Amgen INC. | $108.35 | 2021-2023 | |
| Incyte Corporation | $89.00 | 2023 | |
| Pfizer INC. | $82.67 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $58.72 | 2025 | Lynparza, Calquence |
| Daiichi Sankyo INC. | $51.08 | 2025 | Enhertu, Datroway |
| Novartis Pharmaceuticals Corporation | $42.81 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.09 | 2025 | Iclusig |
| Genzyme Corporation | $34.04 | 2025 | |
| Celgene Corporation | $32.90 | 2025 | Reblozyl |
| Glaxosmithkline, LLC. | $32.70 | 2025 | Ojjaara |
| Abbvie INC. | $30.57 | 2024 | |
| Taiho Oncology, INC. | $23.66 | 2025 | |
| Beone Medicines USA, INC. | $18.28 | 2025 | Brukinsa |
| Genmab U.S., INC. | $17.16 | 2025 | Tivdak |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $14.79 | 2025 | Cabometyx |
| Bayer Healthcare Pharmaceuticals INC. | $13.85 | 2025 | |
| Stemline Therapeutics INC. | $13.41 | 2024 | Orserdu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.